Literature DB >> 7926313

Repeatability of insulin sensitivity and glucose effectiveness from the minimal model. Implications for study design.

G M Steil1, J Murray, R N Bergman, T A Buchanan.   

Abstract

To determine the repeatability of insulin sensitivity measurements generated by the minimal model, we subjected 11 normal men to 3 frequently sampled intravenous glucose tolerance tests (FSIGTs) over the course of 12 days under conditions of fixed diet and limited physical activity. FSIGTs were analyzed by the minimal model using a full, 30-sample data set, as well as a reduced, 12-sample data set that has been proposed for population studies. Minimal model insulin sensitivity index (SI) calculated from the 30-sample data set averaged 0.8 +/- 0.083 x 10(-4) min-1.(pmol/l)-1 (range 0.10-1.64 x 10(-4) min-1.(pmol/l)-1 with an average interday coefficient of variation (CV) of 20.2 +/- 3.2% (range 6-44%). Glucose effectiveness (SG) was slightly less repeatable, with an average interday variability of 25.1 +/- 8.8%. The mean CVs for first-phase insulin secretion (20.1 +/- 3.5%) and total insulin secretion (21.4 +/- 3.2%) were similar to the CV for SI. Mean insulin sensitivity calculated from the 12-sample data set (0.82 +/- 0.08 x 10(-4) min-1.(pmol/l)-1 was not significantly different from the mean calculated from the full data set (P = 0.37, paired Student's t test). However, the mean CV of SI calculated from the reduced data set tended to be greater than that calculated from the full data set (27.7 +/- 5.4% vs. 20.2 +/- 3.2%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926313     DOI: 10.2337/diab.43.11.1365

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

1.  Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors.

Authors:  Madhu N Rao; Grace A Lee; Carl Grunfeld
Journal:  Am J Infect Dis       Date:  2006-09-30

2.  Sources of glycemic variability--what type of technology is needed?

Authors:  Jonas Kildegaard; Toke Folke Christensen; Ole Kristian Hejlesen
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

3.  The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans.

Authors:  R L Prigeon; M E Røder; D Porte; S E Kahn
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

4.  Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors.

Authors:  J O Clausen; K Borch-Johnsen; H Ibsen; R N Bergman; P Hougaard; K Winther; O Pedersen
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

5.  The effect of recombinant human growth hormone with or without rosiglitazone on hepatic fat content in HIV-1-infected individuals: a randomized clinical trial.

Authors:  Donald P Kotler; Qing He; Ellen S Engelson; Jeanine B Albu; Marshall J Glesby
Journal:  Antivir Ther       Date:  2014-12-23

6.  Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components.

Authors:  M Ader; T C Ni; R N Bergman
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

Review 7.  Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges.

Authors:  Robert S Parker; Gilles Clermont
Journal:  J R Soc Interface       Date:  2010-02-10       Impact factor: 4.118

8.  Insulin sensitivity, food intake, and cravings with premenstrual syndrome: a pilot study.

Authors:  Kimberly K Trout; Lisa Basel-Brown; Michael R Rickels; Mark H Schutta; Maja Petrova; Ellen W Freeman; Nancy C Tkacs; Karen L Teff
Journal:  J Womens Health (Larchmt)       Date:  2008-05       Impact factor: 2.681

9.  Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients.

Authors:  E Vandemeulebroucke; B Keymeulen; K Decochez; I Weets; C De Block; F Féry; U Van de Velde; I Vermeulen; P De Pauw; C Mathieu; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2009-11-07       Impact factor: 10.122

10.  Residual β-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation.

Authors:  Hang Xiang; Chao Yang; Tianyuan Xiang; Zheng Wang; Xin Ge; Fan Li; Yuehan Su; Haixu Chen; Xianyong Huang; Qiang Zeng
Journal:  Stem Cells Transl Med       Date:  2016-03-29       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.